TY  - CHAP
M1  - Book, Section
TI  - Integrative Oncology
A1  - Ploesser, Markus
A2  - Quang, Tony S.
A2  - Taft, Michelle S.
A2  - Beriwal, Sushil
PY  - 2022
T2  - Understanding the Principles and Practice of Legal Oncology
AB  - In  discussing  the  legal  issues  pertaining  to  integrative  and  alternative  healing  methods  in  oncology,  with  a  focus  on  the  liability  concerns  of  medical  practitioners  in  this  field,  there  are  a  number  of  matters  to  consider.  First,  the  nature  of  alternative  therapies  used  in  oncologic  treatment  must  be  considered,  with  particular  reference  to  the  reasons  for  which  cancer  patients  choose  them  and  how  they  are  used  and  whether  these  therapies  are  combined  with  conventional  cancer  treatments  or  used  on  their  own.  These  alternative  treatments  must  also  be  investigated;  there  are  specific  claimed  benefits  for  each  treatment,  and  these  have  been  medically  proven  to  a  greater  or  lesser  degree.  In  particular,  it  is  necessary  to  distinguish  alternative  treatments  from  experimental  treatments  and  to  discuss  the  legislation  pertaining  to  the  provision  of  these  on  the  market,  as  well  as  the  potential  medical  liability  of  treating  physicians.  The  reasons  motivating  cancer  patients  to  choose  to  be  treated  with  these  alternative  treatments  will  also  be  discussed,  including  discussion  of  whether  treating  oncologists  oversee  the  administration  of  these  treatments  or  whether  patients  choose  to  undergo  alternative  treatment  without  the  endorsement  of  their  treating  physician.  In  addition  to  these  issues,  there  are  also  concerns  pertaining  to  consent  that  must  be  considered.  These  matters  are  complicated  and  interlinked,  and  ultimately,  the  primary  aim  of  oncologists  is  to  treat  their  patients  to  the  best  of  their  ability  and  comply  with  the  law.  Thus,  this  chapter  seeks  to  clarify  the  aforementioned  issues.  
SN  - 
PB  - McGraw Hill Education
CY  - New York, NY
Y2  - 2024/04/23
UR  - hemonc.mhmedical.com/content.aspx?aid=1191392751
ER  -